List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 34 studies with search of: Macedonia, The Former Yugoslav Republic of
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Post-Authorization Safety Study in CKD Subjects Receiving HX575 i.v.
Condition: Chronic Kidney Disease
Intervention: Drug: HX575 recombinant human erythropoietin alfa
2 Recruiting Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
3 Active, not recruiting ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study
Condition: Diabetes
Interventions: Drug: Placebo;   Drug: AGI-1067;   Drug: AGI-1067
4 Recruiting Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBF 1120;   Drug: placebo;   Drug: pemetrexed
5 Recruiting A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Subjects With Metastatic Breast Cancer Receiving Standard Chemotherapy
Conditions: Neoplasm Metastasis;   Breast Cancer
Intervention: Drug: epoetin alfa
6 Recruiting A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Taspoglutide;   Drug: placebo
7 Recruiting Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
Conditions: Male;   Hypogonadism
Intervention: Drug: Testosterone Undecanoate (Nebido, BAY86-5037)
8 Active, not recruiting Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: chlorambucil;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
9 Recruiting AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs
Condition: Bronchitis, Chronic
Intervention: Drug: Avelox (Moxiflxacin, BAY12-8039)
10 Active, not recruiting Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
11 Recruiting Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty.
Condition: Venous Thromboembolism
Interventions: Drug: Xarelto, Rivaroxaban (BAY59-7939);   Drug: Standard care treatment for VTE prophylaxis
12 Recruiting A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Dialysis;   Hyperphosphatemia
Interventions: Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®);   Drug: Another Phosphate binder
13 Completed Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: insulin NPH;   Drug: insulin aspart
14 Active, not recruiting Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: vinblastine;   Drug: vindesine;   Drug: vinorelbine ditartrate;   Radiation: radiation therapy
15 Recruiting Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients
Condition: Chronic Renal Failure
Intervention:
16 Completed CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE With An Adjustable Maintenance Dose Of SYMBICORT
Condition: Asthma
Intervention: Drug: Salmeterol/fluticasone propionate or formoterol/budesonide
17 Recruiting Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Alemtuzumab (MabCampath, BAY86-5045)
18 Completed Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: insulin NPH;   Drug: insulin aspart
19 Active, not recruiting Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Condition: Benign Prostatic Hypertrophy
Interventions: Drug: cetrorelix;   Drug: cetrorelix;   Drug: placebo
20 Active, not recruiting Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
Condition: Lung Cancer
Intervention: Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-34)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services